Membranoproliferative glomerulonephritis type i in renal transplantation patients: A single-center study of a cohort of 68 renal transplants followed up for 11 years

Transplantation

Volumn 91, Issue 11, 2011, Pages 1233-1239

  Moroni, Gabriella ^a   Casati, Costanza ^a   Quaglini, Silvana ^b   Gallelli, Beniamina ^a   Banfi, Giovanni ^a   Montagnino, Giuseppe ^a   Messa, Piergiorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Membranoproliferative glomerulonephritis; Recurrence of glomerulonephritis; Renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85027934405     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318218e94e     Document Type: Article

References (22)

1. Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol 2009; 12: 1322.
2. Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): An update. J Am Soc Nephrol 2005; 16: 1392.
3. Shimizu T, Tanabe K, Oshima T, et al. Recurrence of membranoproliferative glomerulonephritis in renal allografts. Transplant Proc 1998; 30: 3910.
4. Andresdottir MB, Assmann KJ, Hoitsma AJ, et al. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors, and impact on graft survival. Transplantation 1997; 63: 1628.
5. Andresdottir MB, Assmann KJ, Hoitsma AJ, et al. Renal transplantation in patients with dense deposit disease: Morphological characteristics of recurrent disease and clinical outcome. Nephrol Dial Transplant 1999; 14: 1723.
6. Braun MC, Stablein DM, Hamiwka LA, et al. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 2005; 16: 2225.
7. Little MA, Dupont P, Campbell E, et al. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 2006; 69: 504.
8. Lorenz EC, Sethi S, Leung N, et al. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int 2010; 77: 721.
9. Karakayali FY, Ozdemir H, Kivrakdal S, et al. Recurrent glomerular diseases after renal transplantation. Transplant Proc 2006; 38: 470.
10. Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14: 564.
11. Andresdottir MB, Assmann KJ, Koene RA, et al. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 1998; 32: 582.
12. Berthoux FC, Ducret F, Colon S, et al. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): Relationship between the high frequency of recurrent glomerulonephritis and hypocomplementemia. Kidney Int Suppl. 1975: 323.
13. McLean RH, Geiger H, Burke B, et al. Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Serum complement component studies. Am J Med 1976; 60: 60.
14. Am H, Cosio FG. Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 2009; 20: 2490.
15. Montagnino G, Banfi G, Campise MR, et al. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation. Nephrol Dial Transplant 2004; 19: 2622.
16. Cahen R, Trolliet P, Dijoud F, et al. Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: Remission on steroids and cyclophosphamide. Transplant Proc 1995; 27: 1746.
17. Kurtz KA, Schlueter AJ. Management of membranoproliferative glomerulonephritis type II with plasmapheresis. J Clin Apher 2002; 17: 135.
18. Oberkircher OR, Enama M, West JC, et al. Regression of recurrent membranoproliferative glomerulonephritis type II in a transplanted kidney after plasmapheresis therapy. Transplant Proc 1988; 20: 418.
19. Muczynski KA. Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I. Am J Nephrol 1995; 15: 446.
20. Saxena R, Frankel WL, Sedmak DD, et al. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: Successful treatment with plasmapheresis. Am J Kidney Dis 2000; 35: 749.
21. Pickering MC, Cook HT. Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: Novel insights from humans and animals. Clin Exp Immunol 2008; 151: 210.
22. Solez K, Colvin RB, Racusen LC, et al. Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007; 7: 518.